What AI says about ImmunoPrecise Antibodies
ImmunoPrecise Antibodies is a biotech and biotherapeutic research company that combines antibody discovery services with advanced artificial intelligence systems. The company also develops disruptive technologies and biotherapeutic drug discovery platforms, with its subsidiary BioStrand winning the 2024 InterSystems Impact Award for the LENSai platform.
AI named ImmunoPrecise Antibodies in February 2026.
